AU2002308686A1 - Allelic variants of delta opioid receptors associated with disorders of feeding and energy homeostasis - Google Patents

Allelic variants of delta opioid receptors associated with disorders of feeding and energy homeostasis

Info

Publication number
AU2002308686A1
AU2002308686A1 AU2002308686A AU2002308686A AU2002308686A1 AU 2002308686 A1 AU2002308686 A1 AU 2002308686A1 AU 2002308686 A AU2002308686 A AU 2002308686A AU 2002308686 A AU2002308686 A AU 2002308686A AU 2002308686 A1 AU2002308686 A1 AU 2002308686A1
Authority
AU
Australia
Prior art keywords
disorders
feeding
allelic variants
opioid receptors
energy homeostasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002308686A
Inventor
Andrew W. Bergen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOINVEST Ltd
Original Assignee
BIOINVEST Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOINVEST Ltd filed Critical BIOINVEST Ltd
Publication of AU2002308686A1 publication Critical patent/AU2002308686A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002308686A 2001-05-11 2002-05-13 Allelic variants of delta opioid receptors associated with disorders of feeding and energy homeostasis Abandoned AU2002308686A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29001601P 2001-05-11 2001-05-11
US60/290,016 2001-05-11
PCT/US2002/014940 WO2002092838A2 (en) 2001-05-11 2002-05-13 Allelic variants of delta opioid receptors associated with disorders of feeding and energy homeostasis

Publications (1)

Publication Number Publication Date
AU2002308686A1 true AU2002308686A1 (en) 2002-11-25

Family

ID=23114175

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002308686A Abandoned AU2002308686A1 (en) 2001-05-11 2002-05-13 Allelic variants of delta opioid receptors associated with disorders of feeding and energy homeostasis

Country Status (2)

Country Link
AU (1) AU2002308686A1 (en)
WO (1) WO2002092838A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1417338A4 (en) * 2001-07-16 2005-06-29 Price Foundation Ltd Genes and snps associated with eating disorders

Also Published As

Publication number Publication date
WO2002092838A3 (en) 2003-10-16
WO2002092838A2 (en) 2002-11-21

Similar Documents

Publication Publication Date Title
AU2003252478A1 (en) Ccr4 antagonist and medicinal use thereof
EP1450837A4 (en) Interleukin-1 receptors in the treatment of diseases
EP1474445A4 (en) Glycoisoforms of adiponectin and uses thereof
AU2003298913A1 (en) Treatment of inflammatory disorders with 2,3-benzodiazepines
AU2001264920A1 (en) Therapeutic uses of il-1 receptor antagonist
AU2002308686A1 (en) Allelic variants of delta opioid receptors associated with disorders of feeding and energy homeostasis
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
AU2003285686A1 (en) Glycoisoforms of adiponectin and uses thereof
AU2003296871A1 (en) Point feeder and use of point feeder
AU2002339673A1 (en) Agonists and antagonists of ryzn for the treatment of metabolic disorders
EP1324763A4 (en) Stat3 agonists and antagonists and therapeutic uses thereof
AU2002328173A1 (en) Omoxin agonists and antagonists for use in the treatment of metabolic disorders
AU2002339682A1 (en) Emergen agonists and antagonists for use in the treatment of metabolic disorders
AU2002339683A1 (en) Agonist and antagonists of redax for the treatment of metabolic disorders
AU2003246888A1 (en) Use of devazepide in combination with an opioid analgesic for potentiating the effect of the analgesic
AU2002339680A1 (en) Agonists and antagonists of bromix for the treatment of metabolic disorders
AU2002339668A1 (en) Treatment of metabolic disorders with xitar agonists and antagonists
AU2002321769A1 (en) Agonists and antagonists of cobesin for the treatment of metabolic disorders
AU2002339681A1 (en) Agonists and antagonists of glucomin for the treatment of metabolic disorders
AU2002329001A1 (en) Agonists and antagonists of cylixin for the treatment of metabolic disorders
AU2002324300A1 (en) Agonists and antagonists of moceptin for the treatment of metabolic disorders
AU2002324297A1 (en) Agonists and antagonists of moxifin for the treatment of metabolic disorders
AU2002321770A1 (en) Agonists and antagonists of genceptin for the treatment of metabolic disorders
AU2002321766A1 (en) Agonists and antagonists of obesingen for the treatment of metabolic disorders
AU2002321761A1 (en) Agonists and antagonists of disomet for the treatment of metabolic disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase